MAKO-Uni-Knee Arthroplasty Clinical Outcomes and Function

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
Clinical Outcomes
Interventions
PROCEDURE

Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

All patients will receive the RESTORIS MCK (Multicompartmental Knee) Implant System, which is approved for use in unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system. The femoral component is constructed from cobalt chrome (CoCr) and the tibial component is constructed from an ultra-high molecular weight polyethylene (UHMWPE) insert and titanium (Ti) baseplate. UKA will be facilitated with MAKO Robotic-Arm Assisted Surgery, which has been shown in prior studies to lower pain and result in more accurate implant placement than manual UKA in a randomized controlled trial.(15)

Trial Locations (1)

33637

Florida Orthopaedic Institute, Tampa

All Listed Sponsors
collaborator

Stryker Orthopaedics

INDUSTRY

lead

Foundation for Orthopaedic Research and Education

OTHER

NCT03354195 - MAKO-Uni-Knee Arthroplasty Clinical Outcomes and Function | Biotech Hunter | Biotech Hunter